203 related articles for article (PubMed ID: 15053118)
1. Diffuse pollution of surface water by pharmaceutical products.
Derksen JG; Rijs GB; Jongbloed RH
Water Sci Technol; 2004; 49(3):213-21. PubMed ID: 15053118
[TBL] [Abstract][Full Text] [Related]
2. From municipal sewage to drinking water: fate and removal of pharmaceutical residues in the aquatic environment in urban areas.
Heberer T; Reddersen K; Mechlinski A
Water Sci Technol; 2002; 46(3):81-8. PubMed ID: 12227607
[TBL] [Abstract][Full Text] [Related]
3. Persistence of pharmaceutical compounds and other organic wastewater contaminants in a conventional drinking-water-treatment plant.
Stackelberg PE; Furlong ET; Meyer MT; Zaugg SD; Henderson AK; Reissman DB
Sci Total Environ; 2004 Aug; 329(1-3):99-113. PubMed ID: 15262161
[TBL] [Abstract][Full Text] [Related]
4. Occurrence and fate of pharmaceutical products and by-products, from resource to drinking water.
Mompelat S; Le Bot B; Thomas O
Environ Int; 2009 Jul; 35(5):803-14. PubMed ID: 19101037
[TBL] [Abstract][Full Text] [Related]
5. Ecotoxicology of human pharmaceuticals.
Fent K; Weston AA; Caminada D
Aquat Toxicol; 2006 Feb; 76(2):122-59. PubMed ID: 16257063
[TBL] [Abstract][Full Text] [Related]
6. Are pharmaceuticals potent environmental pollutants? Part I: environmental risk assessments of selected active pharmaceutical ingredients.
Carlsson C; Johansson AK; Alvan G; Bergman K; Kühler T
Sci Total Environ; 2006 Jul; 364(1-3):67-87. PubMed ID: 16257037
[TBL] [Abstract][Full Text] [Related]
7. Screening and human health risk assessment of pharmaceuticals and their transformation products in Dutch surface waters and drinking water.
de Jongh CM; Kooij PJ; de Voogt P; ter Laak TL
Sci Total Environ; 2012 Jun; 427-428():70-7. PubMed ID: 22551934
[TBL] [Abstract][Full Text] [Related]
8. A multispecies study to assess the toxic and genotoxic effect of pharmaceuticals: furosemide and its photoproduct.
Isidori M; Nardelli A; Parrella A; Pascarella L; Previtera L
Chemosphere; 2006 May; 63(5):785-93. PubMed ID: 16213548
[TBL] [Abstract][Full Text] [Related]
9. A comparison of human pharmaceutical concentrations in raw municipal wastewater and yellowwater.
Winker M; Faika D; Gulyas H; Otterpohl R
Sci Total Environ; 2008 Jul; 399(1-3):96-104. PubMed ID: 18455216
[TBL] [Abstract][Full Text] [Related]
10. Ecotoxicological aspects related to the presence of pharmaceuticals in the aquatic environment.
Santos LH; Araújo AN; Fachini A; Pena A; Delerue-Matos C; Montenegro MC
J Hazard Mater; 2010 Mar; 175(1-3):45-95. PubMed ID: 19954887
[TBL] [Abstract][Full Text] [Related]
11. Workshop 6 (synthesis): monitoring, understanding and managing waste fluxes within a drainage basin.
Fallenius UB
Water Sci Technol; 2004; 49(7):187-8. PubMed ID: 15195437
[TBL] [Abstract][Full Text] [Related]
12. Endocrine disrupting compounds (EDCs) and pharmaceuticals and personal care products (PPCPs) in the aquatic environment: implications for the drinking water industry and global environmental health.
Rahman MF; Yanful EK; Jasim SY
J Water Health; 2009 Jun; 7(2):224-43. PubMed ID: 19240349
[TBL] [Abstract][Full Text] [Related]
13. Probabilistic environmental risk characterization of pharmaceuticals in sewage treatment plant discharges.
Christensen AM; Markussen B; Baun A; Halling-Sørensen B
Chemosphere; 2009 Oct; 77(3):351-8. PubMed ID: 19682723
[TBL] [Abstract][Full Text] [Related]
14. Human pharmaceuticals in surface waters. Implementation of a prioritization methodology and application to the French situation.
Besse JP; Garric J
Toxicol Lett; 2008 Jan; 176(2):104-23. PubMed ID: 18077113
[TBL] [Abstract][Full Text] [Related]
15. A ranking of European veterinary medicines based on environmental risks.
Kools SA; Boxall A; Moltmann JF; Bryning G; Koschorreck J; Knacker T
Integr Environ Assess Manag; 2008 Oct; 4(4):399-408. PubMed ID: 18563959
[TBL] [Abstract][Full Text] [Related]
16. Are pharmaceuticals potent environmental pollutants? Part II: environmental risk assessments of selected pharmaceutical excipients.
Carlsson C; Johansson AK; Alvan G; Bergman K; Kühler T
Sci Total Environ; 2006 Jul; 364(1-3):88-95. PubMed ID: 16260028
[TBL] [Abstract][Full Text] [Related]
17. Invisible pollution: the impact of pharmaceuticals in the water supply.
Strauch KA
AAOHN J; 2011 Dec; 59(12):525-32; quiz 533. PubMed ID: 22132751
[TBL] [Abstract][Full Text] [Related]
18. Human pharmaceuticals in US surface waters: a human health risk assessment.
Schwab BW; Hayes EP; Fiori JM; Mastrocco FJ; Roden NM; Cragin D; Meyerhoff RD; D'Aco VJ; Anderson PD
Regul Toxicol Pharmacol; 2005 Aug; 42(3):296-312. PubMed ID: 15979221
[TBL] [Abstract][Full Text] [Related]
19. [A pilot study for the assessment of pharmaceuticals as water contaminants].
Bottoni P; Fidente R
Ann Ist Super Sanita; 2005; 41(3):333-42. PubMed ID: 16552124
[TBL] [Abstract][Full Text] [Related]
20. Development of a common priority list of pharmaceuticals relevant for the water cycle.
de Voogt P; Janex-Habibi ML; Sacher F; Puijker L; Mons M
Water Sci Technol; 2009; 59(1):39-46. PubMed ID: 19151484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
